Cargando…

Performance Characteristics of the Cepheid Xpert MTB/RIF Test in a Tuberculosis Prevalence Survey

BACKGROUND: Xpert MTB/RIF (“Xpert”) is a molecular test for detection of Mycobacterium tuberculosis (MTB) in sputum. Performance characteristics have been established for its use during passive tuberculosis (TB) case detection in symptomatic TB suspects, but Xpert performance has not been assessed i...

Descripción completa

Detalles Bibliográficos
Autores principales: Dorman, Susan E., Chihota, Violet N., Lewis, James J., Shah, Maunank, Clark, David, Grant, Alison D., Churchyard, Gavin J., Fielding, Katherine L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3419700/
https://www.ncbi.nlm.nih.gov/pubmed/22905254
http://dx.doi.org/10.1371/journal.pone.0043307
_version_ 1782240762687127552
author Dorman, Susan E.
Chihota, Violet N.
Lewis, James J.
Shah, Maunank
Clark, David
Grant, Alison D.
Churchyard, Gavin J.
Fielding, Katherine L.
author_facet Dorman, Susan E.
Chihota, Violet N.
Lewis, James J.
Shah, Maunank
Clark, David
Grant, Alison D.
Churchyard, Gavin J.
Fielding, Katherine L.
author_sort Dorman, Susan E.
collection PubMed
description BACKGROUND: Xpert MTB/RIF (“Xpert”) is a molecular test for detection of Mycobacterium tuberculosis (MTB) in sputum. Performance characteristics have been established for its use during passive tuberculosis (TB) case detection in symptomatic TB suspects, but Xpert performance has not been assessed in other settings. Objectives were to determine Xpert performance and costs in the context of a TB prevalence survey. METHODOLOGY/PRINCIPAL FINDINGS: This was a diagnostic sub-study of a TB prevalence survey conducted in gold mining companies in South Africa. Sputa (one per participant) were tested using smear microscopy, liquid culture (reference comparator), and Xpert. Costs were collected using an ingredients approach and analyzed using a public health program perspective. 6893 participants provided a sputum specimen. 187/6893 (2.7%) were positive for MTB in culture, 144/6893 (2.1%) were positive for MTB by Xpert, and 91/6893 (1.3%) were positive for acid fast bacilli by microsocopy. Sensitivity, specificity, positive predictive value, and negative predictive value for detection of MTB by Xpert were 62.6% (95% confidence interval [CI] 55.2, 69.5), 99.6% (99.4, 99.7), 81.3% (73.9, 87.3), and 98.9 (98.6, 98.8); agreement between Xpert and culture was 98.5% (98.2, 98.8). Sensitivity of microscopy was 17.6% (12.5, 23.9). When individuals with a history of TB treatment were excluded from the analysis, Xpert specificity was 99.8 (99.7, 99.9) and PPV was 90.6 (83.3, 95.4) for detection of MTB. For the testing scenario of 7000 specimens with 2.7% of specimens culture positive for MTB, costs were $165,690 for Xpert and $115,360 for the package of microscopy plus culture. CONCLUSION: In the context of a TB prevalence survey, the Xpert diagnostic yield was substantially higher than that of microscopy yet lower than that of liquid culture. Xpert may be useful as a sole test for TB case detection in prevalence surveys, particularly in settings lacking capacity for liquid culture.
format Online
Article
Text
id pubmed-3419700
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-34197002012-08-17 Performance Characteristics of the Cepheid Xpert MTB/RIF Test in a Tuberculosis Prevalence Survey Dorman, Susan E. Chihota, Violet N. Lewis, James J. Shah, Maunank Clark, David Grant, Alison D. Churchyard, Gavin J. Fielding, Katherine L. PLoS One Research Article BACKGROUND: Xpert MTB/RIF (“Xpert”) is a molecular test for detection of Mycobacterium tuberculosis (MTB) in sputum. Performance characteristics have been established for its use during passive tuberculosis (TB) case detection in symptomatic TB suspects, but Xpert performance has not been assessed in other settings. Objectives were to determine Xpert performance and costs in the context of a TB prevalence survey. METHODOLOGY/PRINCIPAL FINDINGS: This was a diagnostic sub-study of a TB prevalence survey conducted in gold mining companies in South Africa. Sputa (one per participant) were tested using smear microscopy, liquid culture (reference comparator), and Xpert. Costs were collected using an ingredients approach and analyzed using a public health program perspective. 6893 participants provided a sputum specimen. 187/6893 (2.7%) were positive for MTB in culture, 144/6893 (2.1%) were positive for MTB by Xpert, and 91/6893 (1.3%) were positive for acid fast bacilli by microsocopy. Sensitivity, specificity, positive predictive value, and negative predictive value for detection of MTB by Xpert were 62.6% (95% confidence interval [CI] 55.2, 69.5), 99.6% (99.4, 99.7), 81.3% (73.9, 87.3), and 98.9 (98.6, 98.8); agreement between Xpert and culture was 98.5% (98.2, 98.8). Sensitivity of microscopy was 17.6% (12.5, 23.9). When individuals with a history of TB treatment were excluded from the analysis, Xpert specificity was 99.8 (99.7, 99.9) and PPV was 90.6 (83.3, 95.4) for detection of MTB. For the testing scenario of 7000 specimens with 2.7% of specimens culture positive for MTB, costs were $165,690 for Xpert and $115,360 for the package of microscopy plus culture. CONCLUSION: In the context of a TB prevalence survey, the Xpert diagnostic yield was substantially higher than that of microscopy yet lower than that of liquid culture. Xpert may be useful as a sole test for TB case detection in prevalence surveys, particularly in settings lacking capacity for liquid culture. Public Library of Science 2012-08-15 /pmc/articles/PMC3419700/ /pubmed/22905254 http://dx.doi.org/10.1371/journal.pone.0043307 Text en © 2012 Dorman et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Dorman, Susan E.
Chihota, Violet N.
Lewis, James J.
Shah, Maunank
Clark, David
Grant, Alison D.
Churchyard, Gavin J.
Fielding, Katherine L.
Performance Characteristics of the Cepheid Xpert MTB/RIF Test in a Tuberculosis Prevalence Survey
title Performance Characteristics of the Cepheid Xpert MTB/RIF Test in a Tuberculosis Prevalence Survey
title_full Performance Characteristics of the Cepheid Xpert MTB/RIF Test in a Tuberculosis Prevalence Survey
title_fullStr Performance Characteristics of the Cepheid Xpert MTB/RIF Test in a Tuberculosis Prevalence Survey
title_full_unstemmed Performance Characteristics of the Cepheid Xpert MTB/RIF Test in a Tuberculosis Prevalence Survey
title_short Performance Characteristics of the Cepheid Xpert MTB/RIF Test in a Tuberculosis Prevalence Survey
title_sort performance characteristics of the cepheid xpert mtb/rif test in a tuberculosis prevalence survey
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3419700/
https://www.ncbi.nlm.nih.gov/pubmed/22905254
http://dx.doi.org/10.1371/journal.pone.0043307
work_keys_str_mv AT dormansusane performancecharacteristicsofthecepheidxpertmtbriftestinatuberculosisprevalencesurvey
AT chihotavioletn performancecharacteristicsofthecepheidxpertmtbriftestinatuberculosisprevalencesurvey
AT lewisjamesj performancecharacteristicsofthecepheidxpertmtbriftestinatuberculosisprevalencesurvey
AT shahmaunank performancecharacteristicsofthecepheidxpertmtbriftestinatuberculosisprevalencesurvey
AT clarkdavid performancecharacteristicsofthecepheidxpertmtbriftestinatuberculosisprevalencesurvey
AT grantalisond performancecharacteristicsofthecepheidxpertmtbriftestinatuberculosisprevalencesurvey
AT churchyardgavinj performancecharacteristicsofthecepheidxpertmtbriftestinatuberculosisprevalencesurvey
AT fieldingkatherinel performancecharacteristicsofthecepheidxpertmtbriftestinatuberculosisprevalencesurvey